Dentatorubral pallidoluysian atrophy (DRPLA) is a rare, progressive, fatal neuropsychiatric disorder similar to Huntington's disease, caused by an expansion of a CAG trinucleotide repeat encoding glutamine. We have cloned the cDNA of the rat homologue of this gene. The cDNA contains a 3549 base pair open reading frame that is 88.2% identical to the human cDNA, with a predicted amino acid sequence that is 93.6% identical to the human sequence. The consecutive glutamine repeat is only five residues in length (normal range in human: 7-35 glutamines) and is followed by a polymorphic region of alternating glutamine and proline residues (QQQQQPQPQPQPQQ). The sequence also includes a polymorphic proline repeat, a serine repeat, and a region of alternating acidic and basic residues. Northern analysis and in situ hybridization indicate that the gene is widely expressed as a 4.5 kb mRNA, with a neuronal distribution in the brain.The widespread expression of this gene is consistent with the possibility that DRPLA, like other glutamine repeat diseases, is a result of an abnormality at the protein level.
Introduction
DRPLA is a rare neurodegenerative disorder with a variety of symptoms including cerebellar ataxia, myoclonic epilepsy, choreiform movements, psychiatric symptoms, and dementia (Smith et al. 1958 , Naito & Oyangi 1982 . The disease is caused by an expansion of a CAG trinucleotide repeat in a gene localized to chromosome 12p (Koide et al. 1994 , Nagafuchi et al. 1994 , Margolis et al. 1996 . In addition to DRPLA, X-linked spinal and bulbar muscular atrophy (SBMA) (La Spada et al. 1991 ), Huntington's disease (HD) (Huntington's Disease Collaborative Research Group 1993), spinocerebellar atrophy type 1 (SCA1) (Orr et al. 1993) and Machado-Joseph disease (SCA3) (Kawaguchi et al. 1994) are all caused by an expanded CAG repeat encoding glutamine (Ross 1995) . Each of these neuropsychiatric diseases is characterized by a similar number of CAG repeats in normal (about 15-30) and affected (about 40-100) individuals. Expanded repeats tend to increase in length from one generation to the next, primarily in paternal transmission, and repeat length is roughly correlated with disease severity. In addition, the neuropathology found in each disorder is located in focal regions of the central nervous system (CNS). Only in SBMA, where the mutation is caused by a CAG expansion in the androgen receptor (AR), is the gene function known (La Spada et al. 1991) .
Expression of the DRPLA gene appears to be widespread (Nagafuchi et al. 1994 , Yazawa et al. 1995 , Margolis et al. 1996 , although the areas analysed have been limited. The anatomic distribution of gene expression -a potentially important clue in deciphering the pathophysiology of expansion mutation -has been identified in HD (Li et al. 1993a (Li et al. , 1994 , SBMA (Lubahn et al. 1988 , Tan et al. 1988 , Trapman et al. 1988 , and SCA 1 (Banfi et al. 1994) . In each case, gene expression at the mRNA level is not limited to those regions in which pathology is most prominent.
